Immune Checkpoint Inhibitors to Treat Malignant Lymphomas

Genetic and/or epigenetic changes provide antigen-derived diversity in neoplastic cells. Beside, these cells do not initiate immune response of host organisms. A variety of factors are responsible for the resistant to treatment, including individual variations in patients and somatic cell genetic di...

Descripción completa

Detalles Bibliográficos
Autores principales: Witkowska, Magdalena, Smolewski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925139/
https://www.ncbi.nlm.nih.gov/pubmed/29850620
http://dx.doi.org/10.1155/2018/1982423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925139/
https://www.ncbi.nlm.nih.gov/pubmed/29850620
http://dx.doi.org/10.1155/2018/1982423

Ejemplares similares